New dressing could help cancer patients use fewer steroids for painful skin reactions
NCT ID NCT04087629
Summary
This study is testing whether a flexible wound dressing called StrataCTX® can help reduce the need for steroid creams when treating skin reactions. These reactions occur in people with cutaneous T-cell lymphoma (CTCL) or those receiving chemotherapy/immunotherapy for other cancers. Researchers want to see if using this dressing can ease itching and improve quality of life while allowing patients to use less steroid medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CTCL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Irving Medical Center
RECRUITINGNew York, New York, 10032, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.